Editor's Note Insufficient awareness of drug interactions with hormonal contraceptives (HCs) among anesthesia providers could lead to unintended pregnancies and preventable health consequences, according to survey published in Anesthesia & Analgesia. Physician’s Weekly covered the news February 27. The article specifically cites sugammedex and aprepitant, both of which are widely…

Read More

Editor's Note Using powerful synthetic opioids remifentanil and sufentanil during surgery increases risk of patients suffering during recovery, according to a study in the journal Regional Anesthesia & Pain Medicine. HealthDay reported the news February 27. According to the article, researchers analyzed data from 971 patients who underwent surgery—37% orthopedic…

Read More

Editor's Note The OR Business Management Conference this year for the first time offered a lineup of sessions that was fully dedicated to content relevant to ambulatory surgery centers (ASCs). In this session, Collin Pick, MSN, CRNA, ARNP, CMPE, chief of anesthesia, Physician Partners of America, explored the ongoing anesthesia…

Read More

Editor's Note Recent legislative efforts in Florida and Mississippi aim to expand the authority of advanced practice registered nurses (APRNs) with measures that would remove supervisory requirements and allow independent practice for certain nurse practitioners. The efforts underscore an ongoing, nationwide debate over the role of APRNs in addressing provider…

Read More

Editor's Note Implementing a multimodal analgesia-based enhanced recovery after surgery (ERAS) protocol significantly reduced both intraoperative opioid administration and postoperative opioid prescriptions in cardiac surgery patients, according to a January 5 report in Anesthesiology News. The findings were presented at the 2024 International Anesthesia Research Society meeting by Montefiore-Einstein Center…

Read More

Editor's Note Analysts say proposed tariffs on imported goods could increase costs for approximately 75% of medical devices marketed in the United States, 69% of which are manufactured solely abroad, according to a January 20 article in Medical Product Outsourcing. Valued at $197.8 billion in 2023, the US medical device…

Read More

Editor's Note New infection control recommendations from the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) are purportedly the first comprehensive guidelines tailored specifically for regional anesthesia and interventional pain management procedures, such as cortisone injections and drug-delivery implants.   As detailed in the organization’s January 21…

Read More

Editor's Note In a January 9 episode of the Advancing Surgical Care Podcast, ASCA President Mark Wainner engaged Alfonso del Granado, MBA, FACHE, CASC, an ASCA Board member and administrator of Covenant High Plains Surgery Center in Lubbock, Texas, in a discussion focusing on the pressing issue of anesthesia provider…

Read More

Editor's Note Anthem Blue Cross Blue Shield recently reversed its controversial plan to impose time limits on anesthesia coverage after intense backlash from the medical community, including anesthesiologists and patient advocates. The policy, aimed at curbing alleged overbilling, would have restricted payments based on average surgery times, a move critics…

Read More

Editor's Note Efforts to reduce the risk of postoperative delirium in older patients should focus on preoperative evaluation, anesthesia choices, and medication management, according to the American Society of Anesthesiologists (ASA). Designed specifically for treating adults aged 65 and older undergoing inpatient surgery, these new, evidence-based recommendations are presented in…

Read More